DRUGS see also Crime; Pharmaceuticals

Amendments

Commission on Native Children: establish (S. 246), S3381 [1JN]

Government regulations: improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), S7494 [26OC], H8212 [16NO]

Health: accelerate discovery, development, and delivery of 21st century lifesaving cures and devices (H.R. 6), H5035, H5069, H5071, H5072, H5074, H5076, H5077, H5078 [10JY]

——— accelerate discovery, development, and delivery of 21st century lifesaving cures and devices (H.R. 6), consideration (H. Res. 350), H4984 [9JY]

Law enforcement: facilitate collaboration among criminal justice, juvenile justice, veterans treatment services, mental health treatment services, and substance abuse systems to address needs of mentally ill offenders (S. 993), S8611, S8614 [10DE]

Medicare: treatment of patient encounters in ambulatory surgical centers in determining meaningful electronic health records use (S. 1347), S6425 [5AU]

Mental health: reauthorize and improve programs related to mental health and substance use disorders (S. 1893), S8906, S8908, S8910 [18DE]

Appointments

Senate Caucus on International Narcotics Control, S739 [3FE], S842 [5FE], S946 [11FE]

Articles and editorials

DEA and NSA Team Up to Share Intelligence, Leading to Secret Use of Surveillance in Ordinary Investigations (excerpt), S3164 [20MY]

Down the Opium Rathole, H1851 [24MR]

Excuse for Crushing Kratom—FDA’s Undue Scrutiny Is Unscientific, E1164 [29JY]

New Drug for Triple Negative Breast Cancer Seems Promising—Enzalutamide, H4074 [10JN]

Surprise! Controversial Patriot Act Power Now Overwhelmingly Used in Drug Investigations (excerpt), S3164 [20MY]

Bills and resolutions

Aviation: require air carriers to modify certain policies relative to use of epinephrine for in-flight emergencies (see S. 1972), S6380 [5AU]

Bureau of Prisons: provide for an effective HIV/AIDS program in Federal prisons (see H.R. 768), H853 [5FE]

Chemicals: allow marketing, distribution, or sale of solid antimicrobial copper alloys with certain claims and exclude certain solid antimicrobial copper alloys from regulation as drugs or devices (see H.R. 1424), H1768 [18MR]

Children and youth: promote development of safe drugs for neonates (see S. 2041), S6699 [16SE]

Cocaine: apply reduced sentences for certain cocaine based offenses retroactively for certain offenders (see H.R. 1252), H1609 [4MR]

——— reclassify certain low-level felonies as misdemeanors and eliminate increased penalties for cocaine offenses where the cocaine involved is cocaine base (see S. 1138), S2530 [29AP] (see H.R. 2153), H2768 [30AP]

Commission on Native Children: establish (see S. 246), S420 [22JA] (see H.R. 2751), H4343 [12JN]

Contraceptives: ensure employers cannot prohibit access, call for an FDA study on whether prescriptions are necessary for contraceptives, and allow use of certain health accounts to purchase over-the-counter drugs (see S. 1438), S3238 [21MY]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana (see S. 134), S100 [8JA] (see H.R. 525), H581 [26JA]

Courts: clarify circumstances under which the enhanced penalty provisions for subsequent convictions apply (see H.R. 1254), H1609 [4MR]

——— eliminate mandatory minimum sentences for all drug offenses (see H.R. 3489), H5942 [10SE] (see H.R. 3530), H6075 [16SE]

——— permit expungement of records of certain marijuana-related offenses (see H.R. 3124), H5329 [21JY]

——— provide certain protections from civil liability for individuals prescribing or administering opioid overdose drugs (see S. 707), S1438 [11MR] (see H.R. 1821), H2269 [15AP]

——— reform sentencing laws (see H.R. 3713), H6935 [8OC]

Crime: address sentencing disparity between crack and powder cocaine (see H.R. 1255), H1609 [4MR]

——— deploy Border Patrol agents and increase number of DEA and ATF agents along U.S. border to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (see H.R. 43), H37 [6JA]

——— enhance penalties for marketing candy-flavored controlled substances to minors (see S. 724), S1494 [12MR]

——— improve Federal sentencing and corrections system by reducing crime, curtailing over-criminalization, concentrating prison space on violent and career criminals, and reducing recidivism (see H.R. 2944), H4771 [25JN]

——— reform and establish mandatory minimum sentences for certain offenses to provide more flexibility and reduce recidivism among Federal inmates (see S. 2123), S7102 [1OC]

——— seal or expunge nonviolent criminal records, reform treatment of juveniles in the justice system, and lift ban on certain Federal benefits for low-level drug offenders (see S. 675), S1335 [9MR] (see H.R. 1672), H2108 [26MR]

Cuba: facilitate export of U.S. agricultural products, remove impediments to export of medical devices and medicines, allow travel by U.S. citizens, and establish an agricultural export promotion program (see H.R. 635), H702 [2FE]

Death and dying: reduce deaths occurring from overdoses (see S. 1654), S4544 [23JN] (see H.R. 2850), H4591 [23JN]

Dept. of Agriculture: prohibit use of Supplemental Nutrition Assistance Program benefits to purchase marijuana products (see H.R. 2331), H3211 [14MY]

Dept. of Education: exclude certain marijuana-related offenses from drug-related offenses that result in students being barred from receiving Federal educational loans, grants, and work assistance (see H.R. 3561), H6178 [18SE]

——— repeal suspension of eligibility for grants, loans, and work assistance for drug-related offenses (see H.R. 4004), H8239 [16NO]

Dept. of HHS: amend and reauthorize National All Schedules Prescription Electronic Reporting (NASPER) Grant Program (see S. 480), S982 [12FE] (see H.R. 1725), H2111 [26MR]

——— carry out a grant program for co-prescribing opioid overdose reversal drugs (see H.R. 3680), H6787 [1OC]

——— conduct a pilot project to investigate how to improve medication adherence for individuals with chronic diseases (see H.R. 4292), H10710 [18DE]

——— conduct or support a comprehensive study comparing total health outcomes, including risk of autism, in vaccinated populations and unvaccinated populations (see H.R. 1636), H2033 [25MR]

——— establish grant program to provide supportive services in permanent supportive housing for chronically homeless individuals and families (see H.R. 1293), H1611 [4MR]

——— facilitate responsible dissemination of scientific and medical information not included in the approved labeling of drugs and devices (see H.R. 2414), H3387 [19MY]

——— grant provisional approval to fast-tracked drugs used in therapies and treatments for life-threatening diseases (see H.R. 1376), H1661 [16MR]

——— limit copayment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the amount applicable to drugs in a non-preferred brand drug tier (see H.R. 1600), H2031 [25MR]

——— prevent abuse of dextromethorphan by restricting over-the-counter sales and bulk distribution of cough medicines by teenagers (see H.R. 3250), H5588 [28JY]

——— prevent and treat prenatal opioid abuse and neonatal abstinence syndrome (see S. 799), S1660 [19MR] (see H.R. 1462), H1801 [19MR]

——— promulgate regulations on patient medication information to ensure patients receive consistent and high-quality information about prescription drugs (see S. 2214), S7594 [28OC]

——— reauthorize certain programs relative to national health security (see S. 2055), S6809 [17SE]

——— reauthorize residential treatment programs for pregnant and postpartum women and provide grants to State substance abuse agencies to promote innovative service delivery models for such women (see S. 2226), S7722 [3NO] (see H.R. 3691), H6835 [6OC]

——— require children enrolled in Head Start and Early Head Start programs be vaccinated (see S. 486), S982 [12FE] (see H.R. 933), H1034 [12FE]

——— require NIH to consider sex differences in medical research and direct FDA to guarantee clinical drug trials are sufficient to determine safety and effectiveness for both men and women (see H.R. 2101), H2653 [29AP]

Dept. of Homeland Security: conduct a northern border threat analysis (see S. 1808), S5210 [21JY]

——— make anthrax vaccines and antimicrobials available to emergency response providers (see S. 1915), S6239 [3AU] (see H.R. 1300), H1612 [4MR]

Dept. of Justice: authorize veterans’ treatment courts and encourage services for veterans through drug courts (see H.R. 613), H662 [28JA]

——— award grants to address prescription opioid abuse and heroin use (see S. 524), S983 [12FE] (see H.R. 953), H1035 [12FE]

——— exempt certain products from Controlled Substances Act requirements on scheduled listed chemicals if it is not practical to use such products in illicit manufacture of methamphetamine (see H.R. 3968), H8151 [5NO]

——— improve enforcement efforts relative to prescription drug diversion and abuse (see S. 483), S982 [12FE] (see H.R. 471), H530 [22JA]

——— make the Controlled Substances Act inapplicable to marijuana in States that have legalized marijuana and have State regulations in effect to protect certain Federal interests (see H.R. 3746), H6974 [9OC]

——— prohibit use of amounts from Asset Forfeiture Fund for DEA Domestic Cannabis Suppression/Eradication Program (see H.R. 3518), H6074 [16SE]

——— provide grants for drug disposal sites (see H.R. 2463), H3505 [20MY]

——— provide grants to establish and maintain Tribal Healing to Wellness Courts to adjudicate alcohol or drug cases through extensive supervision and treatment programs (see S. 2205), S7470 [22OC]

——— provide with additional tools to target extraterritorial drug trafficking activity (see S. 32), S11 [6JA] (see H.R. 3380), H5766 [29JY]

Dept. of Transportation: recognize hair as an alternative specimen for preemployment and random controlled substances testing of commercial motor vehicle drivers (see S. 806), S1660 [19MR] (see H.R. 1467), H1801 [19MR]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs (see H.R. 667), H754 [3FE]

——— disclose certain information to State controlled substance monitoring programs (see H.R. 4279), H9374 [16DE]

——— furnish non-formulary drugs and medicines to veterans diagnosed with mental health disorders (see H.R. 2123), H2766 [30AP]

——— improve participation in State prescription drug monitoring programs (see H.R. 2046), H2496 [28AP]

——— improve use of opioids in treating veterans, improve patient advocacy, and expand availability of complementary and integrative health (see S. 1641), S4346 [22JN] (see H.R. 4063), H8359 [18NO]

——— provide for certain requirements relative to immunization of veterans (see S. 172), S201 [13JA]

Depts. of Defense and Veterans Affairs: establish a joint uniform formulary for systemic pain and psychotropic drugs critical to transitioning treatment of an individual between Depts. (see S. 1721), S4841 [8JY]

Diseases: commemorate discovery of polio vaccine and support Federal and international efforts to eradicate disease (see S. Res. 108), S1781 [24MR]

——— facilitate effective research on, and treatment of, neglected tropical diseases, including ebola, through coordinated domestic and international efforts (see H.R. 1797), H2268 [15AP]

——— recognize importance of a continued commitment to ending pediatric AIDS worldwide (see H. Res. 265), H3252 [15MY]

——— require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than for cancer medications administered by a health care provider (see S. 1566), S4103 [11JN] (see H.R. 2739), H4241 [11JN]

Drug abuse: address prescription opioid and heroin abuse (see S. 1134), S2530 [29AP] (see H.R. 2805), H4491 [17JN]

——— combat heroin epidemic and assist forensic labs with addressing seized drug identification backlogs (see S. 2241), S7771 [4NO]

——— making appropriations to address heroin and opioid drug abuse epidemic (see S. 2423), S8883 [18DE]

——— modernize treatment of opioid addiction (see H.R. 2872), H4650 [24JN]

——— provide comprehensive approach to eradicate heroin epidemic (see H.R. 3719), H6935 [8OC]

——— reduce opioid misuse and abuse (see H.R. 3677), H6787 [1OC]

Drunken driving: designate a national day of remembrance for victims of drunken and drugged driving and for victims of consequences of underage drinking (see S. Res. 328), S8379 [3DE]

FAA: initiate a rulemaking relative to upgrading aircraft medical kits for children on airplanes (see H.R. 3379), H5766 [29JY]

FDA: allow the sponsor of an application for the approval of a targeted drug to rely upon data and information with respect to such sponsor’s previously approved targeted drugs (see S. 2030), S6651 [15SE]

——— amend policies relative to approval of certain antibacterial and antifungal drugs (see H.R. 2629), H3877 [3JN]

——— approve certain drugs and biological products for use in a limited population of patients to address increases in bacterial and fungal resistance to drugs and biological products (see H.R. 931), H1033 [12FE]

——— award grants for studying the process of continuous drug manufacturing (see H.R. 2444), H3388 [19MY]

——— clarify definition and regulation of combination products (see S. 1767), S5129 [15JY]

——— create a limited population pathway for approval of certain antibacterial drugs (see S. 185), S238 [16JA]

——— develop and use patient experience data to enhance structured risk-benefit framework in drug regulatory decisionmaking (see H.R. 2338), H3212 [14MY]

——— enhance reporting requirements pertaining to use of antimicrobial drugs in food animals (see H.R. 2459), H3388 [19MY]

——— enhance the process for reviewing combination products (see H.R. 2433), H3387 [19MY]

——— ensure efficiency of clinical trials through broader application of Bayesian statistics and adaptive trial designs (see H.R. 2438), H3387 [19MY]

——— ensure eligible product developers have competitive access to approved drugs and licensed biological products to enable development and testing of new products (see H.R. 2841), H4541 [18JN]

——— ensure valid generic drugs may enter the market (see S. 131), S100 [8JA]

——— establish procedures regarding approval of opioid drugs (see S. 954), S2220 [15AP]

——— establish streamlined data review program relative to approval of licensure of certain drugs (see H.R. 2415), H3387 [19MY]

——— evaluate potential use of evidence from clinical experience to help support approval of new indications for approved drugs (see H.R. 2416), H3387 [19MY]

——— exempt certain user fees from budget sequestration (see H.R. 1078), H1163 [25FE]

——— expedite review of pharmaceuticals approved for marketing in the European Union (see H.R. 1455), H1769 [18MR]

——— extend market exclusivity periods for certain new drug applications and abbreviated new drug applications (see H.R. 1353), H1635 [13MR]

——— extend market exclusivity periods for drugs approved to prevent, diagnose, or treat a rare disease or condition (see S. 1421), S3237 [21MY] (see H.R. 971), H1067 [13FE]

——— extend the rare pediatric disease priority review voucher program (see S. 1878), S6073 [28JY]

——— facilitate dissemination of health care economic information (see H.R. 2452), H3388 [19MY]

——— incentivize the development of abuse-deterrent drugs (see H.R. 2335), H3212 [14MY]

——— issue guidance on precision medicine (see H.R. 2455), H3388 [19MY]

——— modify composition and size of Reagan-Udall Foundation Board of Directors (see H.R. 2435), H3387 [19MY]

——— permit the sale of, and access to, ‘‘research use only’’ products in diagnostic tests (see H.R. 298), H357 [13JA]

——— preserve effectiveness of medically important antimicrobials used in treatment of animal diseases in order to minimize development of antibiotic-resistant bacteria (see S. 621), S1217 [2MR]

——— promote use of innovative statistical methods in clinical protocols for drugs, biological products and devices, and postapproval studies and clinical trials (see H.R. 1066), H1163 [25FE]

——— provide for development of accelerated approval development plans for investigational drugs and biological products (see H.R. 2547), H3560 [21MY]

——— provide for issuance of up-to-date regulations and guidance applying to dissemination by means of Internet of information about medical products (see H.R. 2479), H3506 [20MY]

——— provide incentives for the development of new combination drugs (see H.R. 406), H429 [20JA]

——— reform program allowing for expanded access to certain experimental treatments or breakthrough drugs for seriously ill patients (see H.R. 909), H1032 [12FE]

——— require the label of drugs to contain a parenthetical statement identifying the source of any ingredient constituting or derived from a grain or starch-containing ingredient (see H.R. 3648), H6705 [29SE]

——— strengthen regulation of compounding drugs by pharmacies (see S. 1406), S3183 [20MY]

Federal employees: ensure Federal Employees Health Benefit Program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits (see H.R. 2175), H2769 [30AP]

FEMA: codify authority to use Urban Areas Security Initiative and State Homeland Security Grant Program funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities (see H.R. 361), H404 [14JA]

Financial institutions: create protections for depository institutions that provide financial services to marijuana-related businesses (see S. 1726), S4953 [9JY] (see H.R. 2076), H2497 [28AP]

Foreign trade: remove regulatory barriers to re-exportation of controlled substances among European Economic Area countries (see H.R. 2340), H3212 [14MY]

FTC: issue rules to promote competition and help consumers save money by giving them the freedom to choose where they buy prescription pet medications (see S. 1200), S2687 [6MY] (see H.R. 3174), H5465 [23JY]

GAO: assess the FDA’s current regulatory pathway for reviewing generic versions of nonbiologic complex drug products (see H.R. 1576), H1899 [24MR]

Government regulations: clarify how synthetic drugs known as analogues are to be regulated (see H.R. 3537), H6136 [17SE]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (see S. 481), S982 [12FE] (see H.R. 639), H702 [2FE]

——— increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (see S. 1431), S3237 [21MY]

Health: accelerate discovery, development, and delivery of 21st century lifesaving cures and devices (see H.R. 6), H3386 [19MY]

——— accelerate discovery, development, and delivery of 21st century lifesaving cures and devices (H.R. 6), consideration (see H. Res. 350), H4954 [8JY]

——— authorize use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law (see H.R. 3012), H5029 [9JY]

——— establish programs for health care provider training in Federal health care and medical facilities, establish Federal co-prescribing guidelines, and establish a grant program relative to naloxone (see S. 2256), S7814 [5NO]

——— improve access, certainty, and innovation relative to vaccines (see H.R. 786), H854 [5FE]

——— provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad (see S. 2388), S8602 [10DE]

——— recognize importance of vaccinations and immunizations (see H. Res. 117), H1069 [13FE]

——— recognize right of individuals to have personal control over medical assistance and treatment necessary to alleviate intolerable physical suffering (see S. 2204), S7470 [22OC]

——— reduce prescription drug misuse and abuse (see S. 636), S1246 [3MR]

——— require certain drug manufacturers entering into settlement agreements for violations of law to make supplemental payments to be used to increase medical research funding (see S. 320), S653 [29JA] (see H.R. 744), H812 [4FE]

Health care professionals: authorize physicians to transport controlled substances from a practice setting to another practice setting or disaster area (see H.R. 3014), H5029 [9JY]

——— increase access to opioid addiction treatment by expanding ability of medical professionals to provide medication-assisted therapies (see S. 1455), S3309 [22MY] (see H.R. 2536), H3560 [21MY]

——— require certain practitioners authorized to prescribe controlled substances to complete continuing education (see S. 1392), S3183 [20MY] (see H.R. 3889), H7623 [3NO]

Housing: require disclosure by anyone selling a home or a landlord about previous manufacturing of methamphetamine in such homes to buyers or renters (see S. 2405), S8684 [15DE]

Insurance: expand eligibility for reimbursement for smoking cessation services to include copayments for such services by covered beneficiaries under TRICARE who are eligible for Medicare (see S. 1313), S2849 [13MY]

Law enforcement: combat heroin and methamphetamine trafficking across the Southern border of the U.S. (see S. 392), S832 [5FE]

——— eliminate racial profiling by officers, promote accountability for law enforcement agencies, reenfranchise citizens, eliminate sentencing disparities, and promote re-entry and employment programs (see S. 1610), S4298 [18JN]

——— establish a list of synthetic drugs known as analogues and prohibit most importation, amend sentencing for violations, and improve regulation relative to such analogues (see H.R. 4229), H9270 [10DE]

——— facilitate collaboration among criminal justice, juvenile justice, veterans treatment services, mental health treatment services, and substance abuse systems to address needs of mentally ill offenders (see S. 993), S2245 [16AP] (see H.R. 1854), H2306 [16AP]

——— focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (see S. 502), S983 [12FE] (see H.R. 920), H1033 [12FE]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (see S. 36), S11 [6JA] (see S. 1327), S2850 [13MY] (see H.R. 1186), H1499 [27FE]

——— increase evidentiary standard for drug convictions and require screening of law enforcement officers or others acting under color of law participating in drug task forces (see H.R. 46), H37 [6JA]

——— increase penalties for fentanyl trafficking (see S. 2027), S6605 [10SE] (see H.R. 4183), H9011 [3DE]

——— strengthen mental health system, improve public safety, and reauthorize and improve the National Instant Criminal Background Check System (see S. 2002), S6381 [5AU] (see H.R. 3722), H6935 [8OC]

Marijuana: decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol (see H.R. 1013), H1084 [20FE]

——— end Federal ban of medical marijuana, allow importation of certain derivatives, allow banks to work with medical marijuana businesses, enable medicinal research, and allow prescription to veterans (see S. 683), S1383 [10MR] (see H.R. 1538), H1847 [23MR]

——— exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana (see S. 1333), S2850 [13MY] (see H.R. 1635), H2033 [25MR]

——— exempt real property from civil forfeiture due to medical-marijuana-related conduct authorized by State law (see H.R. 262), H188 [9JA]

——— limit application of Federal laws to distribution and consumption (see S. 2237), S7771 [4NO]

——— prohibit Federal prosecution of residents who are acting in accordance with their State’s marijuana laws (see H.R. 1940), H2415 [22AP]

——— provide for legitimate use of medicinal marijuana in accordance with State laws (see H.R. 2373), H3252 [15MY]

——— provide that Federal law shall not preempt State law (see H.R. 3629), H6306 [28SE]

——— reschedule marijuana under the Controlled Substances Act, allow for medicinal use of marijuana in accordance with State laws, and exclude cannabidiol from the definition of marijuana (see H.R. 1774), H2209 [14AP]

Medicaid: allow for payments to States for substance abuse services furnished to inmates in public institutions (see H.R. 4076), H8360 [18NO]

——— encourage States to adopt administrative procedures relative to nonmedical exemptions from immunization requirements (see S. 1921), S6296 [4AU]

——— provide for the waiver of institutions for mental diseases (IMD) limitation in order to permit coverage for community-based inpatient substance use disorder treatment (see H.R. 1988), H2463 [23AP]

——— provide for updated and alternative certification requirements for participation in the case of certain facilities treating infants under one year of age with neonatal abstinence syndrome (see H.R. 3865), H7346 [29OC]

——— require payment of an additional rebate to State plans in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation (see S. 1364), S2971 [18MY] (see H.R. 2391), H3308 [18MY]

Medicare: apply exceptions process fairly for tiered formulary drugs in prescription drug plans (see S. 1488), S3678 [3JN] (see H.R. 2624), H3877 [3JN]

——— cover supplies associated with insulin injection, home needle removal, decontamination, and disposal devices, and disposal of needles and syringes through a sharps-by-mail or similar program (see S. 1066), S2400 [23AP] (see H.R. 1727), H2111 [26MR]

——— deliver a meaningful drug benefit and lower prescription drug prices (see S. 1884), S6136 [29JY] (see H.R. 3261), H5589 [28JY]

——— ensure equal access of beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage (see S. 1190), S2650 [5MY] (see H.R. 793), H855 [5FE]

——— establish Value-Based Insurance Design demonstration program for use under Medicare Advantage plans, preserve beneficiary choice, and revise treatment of infusion drugs furnished through durable medical equipment (see H.R. 2581), H3581 [29MY]

——— establish Value-Based Insurance Design demonstration program to show that reduced copayments or coinsurance can increase utilization, improve clinical outcomes, and lower health care expenditures (see S. 1396), S3183 [20MY] (see H.R. 2570), H3573 [22MY]

——— exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals (see S. 506), S983 [12FE] (see H.R. 696), H756 [3FE]

——— improve access to medication therapy management (see S. 776), S1628 [18MR]

——— improve formulary requirements for prescription drug plans and Medicare Advantage prescription drug plans relative to certain categories or classes of drugs (see S. 648), S1302 [4MR]

——— improve integrity (see H.R. 1021), H1112 [24FE]

——— make premium and cost-sharing subsidies available to low-income beneficiaries in Puerto Rico or other territories (see S. 2342), S8306 [2DE] (see H.R. 4163), H8970 [2DE]

——— modify payment for outpatient department procedures that utilize drugs as supplies (see S. 1466), S3310 [22MY] (see H.R. 1178), H1499 [27FE]

——— prevent application of budget sequestration to payment for certain physician-administered drugs (see H.R. 1416), H1767 [18MR]

——— provide coverage of pharmacist services in medically underserved areas (see S. 314), S653 [29JA] (see H.R. 592), H660 [28JA]

——— provide for a pharmaceutical and technology ombudsman (see H.R. 2325), H3211 [14MY]

——— provide for coverage of home as a site of care for infusion therapy (see S. 275), S589 [28JA] (see H.R. 605), H661 [28JA]

——— provide for pharmacy benefits manager standards under the prescription drug program and transparency of payment methodology of pharmacies (see H.R. 244), H187 [9JA]

——— provide for the coordination of programs to prevent and treat obesity (see S. 1509), S3776 [4JN] (see H.R. 2404), H3309 [18MY]

——— provide programs to prevent prescription drug abuse (see S. 1913), S6187 [30JY] (see H.R. 2298), H2957 [13MY]

——— remove enrollment restriction on certain physicians and practitioners prescribing covered outpatient drugs under the prescription drug program (see H.R. 4062), H8359 [18NO]

——— require drug manufacturers to provide rebates for drugs dispensed to low-income individuals under the prescription drug benefit program (see S. 1083), S2400 [23AP] (see H.R. 2005), H2464 [23AP]

——— require the Dept. of HHS to determine covered part D prescription drug prices for beneficiaries (see H.R. 4207), H9205 [9DE]

——— require the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries (see S. 31), S11 [6JA] (see H.R. 3061), H5172 [14JY]

——— treatment of patient encounters in ambulatory surgical centers in determining meaningful electronic health records use (see S. 1347), S2933 [14MY] (see H.R. 887), H981 [11FE]

Mental health: provide grants to improve treatment of substance use disorders (see S. 1410), S3237 [21MY]

——— reauthorize and improve programs related to mental health and substance use disorders (see S. 1893), S6136 [29JY]

——— strengthen parity in mental health and substance use disorder benefits (see H.R. 4276), H9374 [16DE]

Minorities: improve inclusion in clinical trials (see H.R. 2468), H3505 [20MY]

Motor vehicles: establish requirements on marijuana-impaired driving and direct National Highway Traffic Safety Administration to issue comprehensive guidance on best practices to prevent marijuana-impaired driving (see H.R. 2598), H3641 [1JN]

National Criminal Justice Commission: establish (see S. 1119), S2473 [28AP] (see H.R. 2330), H3211 [14MY]

Native Americans: prevent Indian tribes and tribal organizations that cultivate, manufacture, or distribute marijuana on Indian land from receiving Federal funds (see S. 1984), S6380 [5AU]

Patient Protection and Affordable Care Act: repeal amendments which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements (see S. 709), S1438 [11MR] (see H.R. 1270), H1610 [4MR]

——— repeal amendments which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements and impose contribution caps (see S. 836), S1708 [23MR] (see H.R. 1547), H1848 [23MR]

——— repeal certain provisions in order to lower health premiums and increase choice for small business and individuals (see S. 254), S466 [26JA]

Pharmaceuticals: allow manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients (see H.R. 790), H854 [5FE]

——— allow personal importation and reimportation of prescription drugs (see H.R. 2623), H3877 [3JN]

——— allow personal importation of safe and affordable drugs from approved pharmacies in Canada (see S. 122), S99 [8JA] (see H.R. 2228), H2792 [1MY]

——— allow personal importation of safe and affordable drugs from certain countries (see S. 1790), S5170 [16JY]

——— clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers (see S. 1906), S6186 [30JY] (see H.R. 3618), H6260 [25SE] (see H.R. 3678), H6787 [1OC]

——— ensure greater affordability of prescription drugs (see S. 2023), S6604 [10SE] (see H.R. 3513), H6074 [16SE]

——— preserve effectiveness of medically important antimicrobials used in treatment of human and animal diseases (see H.R. 1552), H1848 [23MR]

——— prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (see S. 2019), S6533 [9SE]

Public welfare programs: prohibit assistance under Temporary Assistance for Needy Families Program from being accessed through an electronic benefit transfer card at stores that sell marijuana (see H.R. 2331), H3211 [14MY] (see H.R. 3010), H5029 [9JY]

——— require certain programs to deny benefits to persons who fail a drug test (see H.R. 3047), H5117 [13JY]

——— require States to implement drug testing program for applicants and recipients of assistance under the Temporary Assistance for Needy Families Program (see S. 64), S58 [7JA]

Research: encourage development and use of new antimicrobial drugs in order to treat antibiotic-resistant infections (see H.R. 512), H532 [22JA]

Social Security: reform (see H.R. 1756), H2152 [13AP]

Sports: improve integrity and safety of interstate horseracing (see H.R. 2641), H3877 [3JN]

——— improve integrity and safety of interstate horseracing by requiring a uniform anti-doping program to be enforced by an independent Thoroughbred Horseracing Anti-Doping Authority (see H.R. 3084), H5289 [16JY]

Substance Abuse and Mental Health Services Administration: award grants to States to expand access to clinically appropriate services for opioid abuse, dependence, or addiction (see H.R. 3676), H6787 [1OC]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (see S. 987), S2244 [16AP] (see H.R. 1855), H2306 [16AP]

——— provide for the taxation of marijuana (see H.R. 1014), H1084 [20FE]

U.S. Sentencing Commission: establish penalties for causing environmental damage while cultivating marijuana or other controlled substances on Federal lands or trespassing on private property (see S. 348), S736 [3FE]

Unemployment: require drug testing as a condition for application and receipt of unemployment compensation (see H.R. 1136), H1369 [26FE]

——— require substance abuse risk assessment and targeted drug testing as a condition for receipt of unemployment compensation (see H.R. 2148), H2767 [30AP]

Urban areas: making emergency supplemental appropriations to address critical challenges and rebuild inner city neighborhoods (see S. 1889), S6136 [29JY] (see H.R. 3295), H5763 [29JY]

Western Hemisphere Drug Policy Commission: establish (see H.R. 1812), H2268 [15AP]

Women: ensure timely access to affordable birth control (see S. 1532), S3925 [9JN] (see H.R. 3163), H5402 [22JY]

World Hepatitis Day: observance (see S. Res. 233), S6073 [28JY] (see H. Res. 390), H5590 [28JY]

Cost Estimates

Improving Regulatory Transparency for New Medical Therapies Act (H.R. 639): CBO, H1641 [16MR]

Letters

Characterization of Donald Trump’s remarks relative to immigration and appropriateness of hosting Saturday Night Live (television show): Representative Gutierrez, H7035 [21OC]

Ensuring Patient Access and Effective Drug Enforcement Act: Representative Goodlatte, Committee on the Judiciary (House), H2330 [21AP]

——— Representative Upton, Committee on Energy and Commerce (House), H2330 [21AP]

First Responder Anthrax Preparedness Act: Representative McCaul, Committee on Homeland Security (House), H5505 [27JY]

——— Representative Upton, Committee on Energy and Commerce (House), H5505 [27JY]

Improving Regulatory Transparency for New Medical Therapies Act: Representative Goodlatte, Committee on the Judiciary (House), H1640 [16MR]

——— Representative Upton, Committee on Energy and Commerce (House), H1640 [16MR]

Medicare budget sequestration elimination extension: several health organizations, H4266 [12JN]

Protecting the Integrity of Medicare Act: Representative Paul Ryan, Committee on Ways and Means (House), H2081 [26MR]

21st Century Cures Act: Representative Lamar Smith, Committee on Science, Space, and Technology (House), H5009 [9JY]

——— Representative Paul Ryan, Committee on Ways and Means (House), H5009 [9JY]

——— Representative Upton, Committee on Energy and Commerce (House), H5009 [9JY]

Messages

National Drug Control Strategy: President Obama, S8014 [17NO], H8277 [17NO]

Remarks in House

American Pharmacists Month: observance, H6846 [7OC], H7016, H7017 [20OC]

Arlington Heights, IL: tribute to Live4Lali Clinic, E435 [26MR]

Bipartisan Task Force To Combat the Heroin Epidemic: establishment, H7013 [20OC]

Centers for Disease Control and Prevention: conduct study to determine how efforts to incentivize development of new antibiotics may impact antibiotic resistance, H5074, H5075 [10JY]

——— whistleblower allegations relative to intentional omission of findings from study examining possible relationship between certain vaccines and autism, H5602 [29JY]

Council Bluffs, IA: anniversary of Oard-Ross Drug (business), E1002 [7JY]

Courts: permit expungement of records of certain marijuana-related offenses (H.R. 3124), E1093 [21JY]

——— provide certain protections from civil liability for individuals prescribing or administering opioid overdose drugs (H.R. 1821), E501 [15AP]

——— reform sentencing laws (H.R. 3713), H7384 [2NO], H8443 [30NO]

Creating Hope Act: reauthorize, H4980 [9JY]

Crime: improve Federal sentencing and corrections system by reducing crime, curtailing over-criminalization, concentrating prison space on violent and career criminals, and reducing recidivism (H.R. 2944), H5288 [16JY], H7380–H7383 [2NO], H8439 [30NO]

——— seal or expunge nonviolent criminal records, reform treatment of juveniles in the justice system, and lift ban on certain Federal benefits for low-level drug offenders (S. 675), H3299 [18MY], E529 [20AP]

DEA: prohibit funding to investigate physicians prescribing certain narcotic drugs for maintenance or detoxification treatment, H3734, H3735 [2JN]

Death and dying: reduce deaths occurring from overdoses (H.R. 2850), E964 [24JN]

Dept. of Defense: U.S. Southern Command (SOUTHCOM) and Joint Interagency Task Force South funding to combat drug trafficking and terrorism in the Western Hemisphere, H3176 [14MY]

Dept. of Education: exclude certain marijuana-related offenses from drug-related offenses that result in students being barred from receiving Federal educational loans, grants, and work assistance (H.R. 3561), E1322 [18SE]

Dept. of HHS: amend and reauthorize National All Schedules Prescription Electronic Reporting (NASPER) Grant Program (H.R. 1725), H4778 [7JY], H5796–H5798 [8SE]

——— establish a Biodefense Injury Compensation Program, E1835 [18DE]

——— establish grant program to provide supportive services in permanent supportive housing for chronically homeless individuals and families (H.R. 1293), E307 [4MR]

——— facilitate responsible dissemination of scientific and medical information not included in the approved labeling of drugs and devices, H4977 [9JY]

——— prevent and treat prenatal opioid abuse and neonatal abstinence syndrome (H.R. 1462), H5798–H5801 [8SE], H7031 [21OC]

——— prevent and treat prenatal opioid abuse and neonatal abstinence syndrome (S. 799), H8180–H8182 [16NO]

Dept. of Homeland Security: conduct a northern border threat analysis (H.R. 455), H7316–H7319 [28OC]

——— develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S., H242 [13JA]

——— make anthrax vaccines and antimicrobials available to emergency response providers (H.R. 1300), H5504–H5506 [27JY]

Dept. of Justice: authorize veterans’ treatment courts and encourage services for veterans through drug courts (H.R. 613), H760 [4FE]

——— award grants to address prescription opioid abuse and heroin use, H3671 [2JN]

——— child abuse assistance programs funding through reductions in DEA funding, H3703 [2JN]

——— drug court program funding, H3669, H3675 [2JN]

——— improve enforcement efforts relative to prescription drug diversion and abuse (H.R. 471), H2329–H2332 [21AP]

——— mental health courts and veterans treatment courts funding, H3680 [2JN]

——— Prescription Drug Monitoring Program funding, H3706 [2JN]

——— prohibit funding to prevent States from implementing laws that authorize the use, distribution, or possession of cannabidiol or cannabidiol oil, H3750–H3752 [2JN]

——— prohibit funding to prevent States from implementing laws that authorize the use, distribution, possession, or cultivation of marijuana on non-Federal lands, H3749, H3750 [2JN]

——— prohibit funding to prevent States from implementing laws that authorize the use, distribution, possession, or cultivation of medical marijuana, H3745–H3747 [2JN]

——— veterans’ treatment courts funding, H3695, H3709, H3710 [2JN]

——— veterans’ treatment courts funding through reductions in ATF funding, H3705, H3706 [2JN]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs (H.R. 667), H8284 [18NO], E153 [3FE]

——— disclose certain information to State controlled substance monitoring programs (H.R. 4279), H9378 [17DE]

——— furnish non-formulary drugs and medicines to veterans diagnosed with mental health disorders, H3177 [14MY]

——— furnish non-formulary drugs and medicines to veterans diagnosed with mental health disorders (H.R. 2123), H2670 [30AP]

——— improve use of opioids in treating veterans, improve patient advocacy, and expand availability of complementary and integrative health (H.R. 4063), H8656 [1DE]

——— prohibit funding to implement prohibition on health care providers providing recommendations and opinions to veterans regarding participation in State marijuana programs, H2607–H2609 [29AP], E636 [30AP], E640 [1MY]

Diseases: facilitate effective research on, and treatment of, neglected tropical diseases, including ebola, through coordinated domestic and international efforts (H.R. 1797), E514 [16AP]

——— increase efforts to combat drug-resistant tuberculosis, E1808 [16DE]

——— require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than for cancer medications administered by a health care provider (H.R. 2739), H4970 [9JY]

District of Columbia: discourage congressional intervention in marijuana legalization initiative, H1577 [4MR]

Drug abuse: address prescription drug and heroin abuse, H7031 [21OC]

——— address prescription opioid and heroin abuse (H.R. 2805), H4778 [7JY]

——— provide comprehensive approach to eradicate heroin epidemic, H7267 [28OC]

——— provide comprehensive approach to eradicate heroin epidemic (H.R. 3719), H7013 [20OC]

El Paso County, TX: tribute to 346th District Court Veterans’ Treatment Court, E1765 [10DE]

FDA: establish streamlined data review program relative to approval of licensure of certain drugs, H4977 [9JY]

——— exempt certain user fees from budget sequestration, H5012 [9JY]

——— extend market exclusivity periods for drugs approved to prevent, diagnose, or treat a rare disease or condition, H5012 [9JY], E1037 [10JY]

——— extend market exclusivity periods for drugs approved to prevent, diagnose, or treat a rare disease or condition (H.R. 971), H2970 [14MY]

——— improve priority review voucher incentive program for expedited review of treatments for tropical and rare pediatric diseases, E1307 [17SE]

——— reform program allowing for expanded access to certain experimental treatments or breakthrough drugs for seriously ill patients, H4980 [9JY]

FEMA: codify authority to use Urban Areas Security Initiative and State Homeland Security Grant Program funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities (H.R. 361), H675–H677 [2FE], E145 [2FE]

Government regulations: improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), H1638–H1641 [16MR]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), Senate amendment, H8212, H8213 [16NO]

Graziano, Michael: tribute to ‘‘Resistance’’ documentary on antibiotic resistance, E394 [24MR]

Health: accelerate discovery, development, and delivery of 21st century lifesaving cures and devices (H.R. 6), H3399 [20MY], H3650 [2JN], H4476 [17JN], H4656 [25JN], H4972, H5008–H5016 [9JY], H5034, H5035–H5082, H5083, H5084 [10JY], H5094 [13JY], H5179, H5219 [15JY], H6219 [24SE], H7266 [28OC], H7399 [3NO], E1031, E1032, E1036–E1038 [10JY], E1045, E1046, E1047 [13JY], E1060, E1061 [14JY], E1069 [15JY]

——— accelerate discovery, development, and delivery of 21st century lifesaving cures and devices (H.R. 6), consideration (H. Res. 350), H4976–H4985 [9JY]

——— importance of immunizations, H903 [10FE]

——— recognize importance of vaccinations and immunizations, H2368 [22AP]

Health care professionals: increase access to opioid addiction treatment by expanding ability of medical professionals to provide medication-assisted therapies (H.R. 2536), H6845 [7OC]

——— tribute to pharmacists, H7016–H7023 [20OC]

Honduras: political reform, H6263 [28SE]

Immigration: secure the border between the U.S. and Mexico, H539 [26JA]

Jefferson County, WV: urge designation as High Intensity Drug Trafficking Area, H8245 [17NO]

Jordan Michael Filler Foundation: tribute to efforts to increase awareness of drug addiction, H5454 [23JY]

Law enforcement: facilitate collaboration among criminal justice, juvenile justice, veterans treatment services, mental health treatment services, and substance abuse systems to address needs of mentally ill offenders (H.R. 1854), H2273 [16AP]

——— focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (H.R. 920), H3299 [18MY], E529 [20AP]

——— use of young drug offenders as confidential informants, H9028 [8DE]

LSC: funding through reductions in DEA funding, H3704, H3705 [2JN], E850 [8JN]

Marijuana: decriminalize marijuana at the Federal level and leave States the power to regulate marijuana, H7031 [21OC], H8284 [18NO]

——— decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol, H985 [12FE]

——— end Federal ban of medical marijuana, allow cultivation, allow importation of hemp, enable medicinal research, and reform Federal enforcement relative to State and local laws, H3584 [1JN]

——— end Federal ban of medical marijuana, allow importation of certain derivatives, allow banks to work with medical marijuana businesses, enable medicinal research, and allow prescription to veterans (H.R. 1538), E385 [23MR]

——— exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana (H.R. 1635), H8435 [30NO], H8656 [1DE]

——— prohibit Federal prosecution of residents who are acting in accordance with their State’s marijuana laws (H.R. 1940), H2414 [22AP], H2461 [23AP]

——— provide that Federal law shall not preempt State law, H6310 [29SE], H9028 [8DE]

Maui Family Support Services, Inc.: tribute, H9214 [10DE]

Medicaid: provide for updated and alternative certification requirements for participation in the case of certain facilities treating infants under one year of age with neonatal abstinence syndrome (H.R. 3865), H8974 [3DE]

——— require payment of an additional rebate to State plans in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation, H7304 [28OC]

Medicare: ensure equal access of beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage (H.R. 793), H7019, H7020 [20OC]

——— establish drug management program under part D to protect at-risk beneficiaries from controlled substance abuse, H4980 [9JY]

——— establish Value-Based Insurance Design demonstration program to show that reduced copayments or coinsurance can increase utilization, improve clinical outcomes, and lower health care expenditures, H739 [3FE]

——— establish Value-Based Insurance Design demonstration program to show that reduced copayments or coinsurance can increase utilization, improve clinical outcomes, and lower health care expenditures (H.R. 2570), H4447, H4479–H4483 [17JN]

——— include information on the coverage of intensive behavioral therapy for obesity in the ‘‘Medicare and You Handbook’’ and coordinate programs to prevent and treat obesity, H2889 [13MY]

——— provide coverage of pharmacist services in medically underserved areas (H.R. 592), H7017, H7019, H7021 [20OC]

——— provide for coverage of home as a site of care for infusion therapy (H.R. 605), H4483 [17JN], E133 [28JA]

——— provide for pharmacy benefits manager standards under the prescription drug program and transparency of payment methodology of pharmacies (H.R. 244), H7017–H7019, H7021–H7023 [20OC], H9029 [8DE]

——— provide for the coordination of programs to prevent and treat obesity (H.R. 2404), H7399 [3NO]

——— provide programs to prevent prescription drug abuse, E1037 [10JY]

——— treatment of patient encounters in ambulatory surgical centers in determining meaningful electronic health records use, H4480, H4481 [17JN]

Mexico: impact of corruption and violence, H5336 [22JY]

Minorities: improve inclusion in clinical trials, H5012 [9JY]

National Alcohol and Drug Addiction Recovery Month: observance, E1393 [30SE]

National Association of Chain Drug Stores: observance of RxIMPACT Day, E378 [23MR]

National security: improve border security, H976–H979 [11FE], H9046 [8DE]

NIH: funding, H8288, H8292 [18NO]

Pain Awareness Month: observance, E1381 [29SE]

Patient Protection and Affordable Care Act: repeal amendments which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements and impose contribution caps (H.R. 1547), H1835 [23MR]

Pharmaceuticals: address rising cost of generic drugs, H6232 [25SE]

——— preserve effectiveness of medically important antimicrobials used in treatment of human and animal diseases (H.R. 1552), E394, E400 [24MR]

Public welfare programs: require certain programs to deny benefits to persons who fail a drug test (H.R. 3047), H5187 [15JY]

Research: encourage development and use of new antimicrobial drugs in order to treat antibiotic-resistant infections, H5075 [10JY]

Rosenberg, Chuck: question of fitness to serve as DEA Administrator relative to comments on medical marijuana, H8284 [18NO]

Social Security: support policies to protect, expand, and secure long-term future, H7262 [28OC]

South St. Paul, MN: tribute to PRO Pharmacy (business), E1008 [7JY]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (H.R. 1855), E512 [16AP]

——— provide for the taxation of marijuana (H.R. 1014), E227 [20FE]

Trump, Donald: characterization of remarks relative to immigration, H4960 [9JY], H5175 [15JY]

——— characterization of remarks relative to immigration and appropriateness of hosting Saturday Night Live (television show), H7035 [21OC], H7747 [5NO]

Tucson, AZ: anniversary to Teen Challenge of Arizona (organization), H5653 [29JY]

Tully, NY: anniversary of Tully Hill Chemical Dependency Center, E1555 [28OC]

West Virginia: address prescription opioid and heroin abuse, H7036 [21OC]

Western Hemisphere Drug Policy Commission: establish (H.R. 1812), E505 [15AP]

Yakima, WA: tribute to Yakima Union Gospel Mission, H6257 [25SE]

Remarks in Senate

Budget: establish a deficit-neutral reserve fund to address methamphetamine abuse, S1878 [25MR]

Colombia: suspension of aerial drug fumigation, S3175 [20MY]

Commission on Native Children: establish (S. 246), S422 [22JA], S3381–S3385 [1JN]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana (S. 134), S102 [8JA], S3762 [4JN]

Correctional institutions: reform Federal prison system, S882 [10FE]

Crime: enhance penalties for marketing candy-flavored controlled substances to minors (S. 724), S1496 [12MR]

——— reform and establish mandatory minimum sentences for certain offenses to provide more flexibility and reduce recidivism among Federal inmates (S. 2123), S7061, S7104 [1OC], S7253–S7256 [8OC], S7374 [21OC], S8326 [3DE]

——— seal or expunge nonviolent criminal records, reform treatment of juveniles in the justice system, and lift ban on certain Federal benefits for low-level drug offenders, S991 [12FE]

——— seal or expunge nonviolent criminal records, reform treatment of juveniles in the justice system, and lift ban on certain Federal benefits for low-level drug offenders (S. 675), S2034 [26MR]

Death and dying: reduce deaths occurring from overdoses (S. 1654), S4548 [23JN]

Dept. of Defense: establish an anti-tunneling defense to protect Israel and southern border of the U.S., S3911 [9JN], S4088 [11JN]

——— prevent abuse and provide accountability in approval process for compound pharmaceuticals, S6366 [5AU]

Dept. of Education: require State plans to include support for the education of children facing substance abuse in the home, S5143, S5145 [16JY]

——— substance abuse recovery support services for students funding, S4909, S4915 [9JY]

Dept. of HHS: prevent and treat prenatal opioid abuse and neonatal abstinence syndrome (S. 799), S1662 [19MR], S7368 [21OC], S7439–S7441 [22OC]

Dept. of Justice: award grants to address prescription opioid abuse and heroin use, S1071 [24FE]

——— award grants to address prescription opioid abuse and heroin use (S. 524), S6275, S6276 [4AU]

——— provide with additional tools to target extraterritorial drug trafficking activity (S. 32), S18 [6JA], S217 [13JA], S7223 [7OC]

Dept. of Veterans Affairs: improve use of opioids in treating veterans, improve patient advocacy, and expand availability of complementary and integrative health (S. 1641), S4539 [23JN]

Diseases: commemorate discovery of polio vaccine and support Federal and international efforts to eradicate disease (S. Res. 108), S2188 [15AP], S7425 [21OC]

Drug abuse: address prescription drug and heroin abuse, S7368 [21OC]

——— address prescription opioid and heroin abuse (S. 1134), S6276 [4AU]

Drunken driving: designate a national day of remembrance for victims of drunken and drugged driving and for victims of consequences of underage drinking (S. Res. 328), S8382 [3DE]

FDA: preserve effectiveness of medically important antimicrobials used in treatment of animal diseases in order to minimize development of antibiotic-resistant bacteria (S. 621), S1218 [2MR]

Furlong, Ken: D.A.R.E. (Drug Abuse Resistance Education) America (organization) Law Enforcement Executive of the Year award recipient, S5926 [27JY]

Government regulations: improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), S7495 [26OC]

Health: establish programs for health care provider training in Federal health care and medical facilities, establish Federal co-prescribing guidelines, and establish a grant program relative to naloxone (S. 2256), S7819 [5NO]

——— require certain drug manufacturers entering into settlement agreements for violations of law to make supplemental payments to be used to increase medical research funding (S. 320), S657 [29JA]

Honduras: political reform, S2095 [13AP]

Law enforcement: assessment of criminal justice system relative to disproportionate incarceration levels of the poor, mentally ill or drug addicted, and minorities, S6878–S6880 [22SE]

——— assessment of criminal justice system relative to disproportionate incareration levels of the poor, mentally ill or drug addicted, and minorities, S991 [12FE]

——— eliminate racial profiling by officers, promote accountability for law enforcement agencies, reenfranchise citizens, eliminate sentencing disparities, and promote re-entry and employment programs (S. 1610), S4302 [18JN], S4593 [24JN], S4626–S4628 [25JN], S6432 [6AU], S8655 [15DE]

——— facilitate collaboration among criminal justice, juvenile justice, veterans treatment services, mental health treatment services, and substance abuse systems to address needs of mentally ill offenders (S. 993), S2251 [16AP], S2266 [20AP], S8614–S8617 [10DE]

——— focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (S. 502), S962, S990–S992 [12FE], S1378–S1380 [10MR], S1576–S1580 [17MR]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (S. 1327), S4337 [22JN]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (S. 36), S19 [6JA]

——— strengthen mental health system, improve public safety, and reauthorize and improve the National Instant Criminal Background Check System (S. 2002), S7235–S7237 [8OC]

Marijuana: decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol, S7620 [29OC]

——— end Federal ban of medical marijuana, allow importation of certain derivatives, allow banks to work with medical marijuana businesses, enable medicinal research, and allow prescription to veterans (S. 683), S1385 [10MR]

Medicare: deliver a meaningful drug benefit and lower prescription drug prices (S. 1884), S7119 [5OC]

——— treatment of patient encounters in ambulatory surgical centers in determining meaningful electronic health records use (S. 1347), S6425 [5AU]

Medicare/Medicaid: deliver a meaningful drug benefit and lower prescription drug prices, S6171 [30JY]

Mental health: reauthorize and improve programs related to mental health and substance use disorders, S8330, S8345 [3DE]

——— reauthorize and improve programs related to mental health and substance use disorders (S. 1893), S8908, S8910 [18DE]

National Association of Chain Drug Stores: observance of RxIMPACT Day, S1707 [23MR]

National security: improve border security, S893–S896 [10FE]

Obama, President: evaluation of administration, S533–S536 [27JA]

——— evaluation of foreign policy, S7198–S7200 [7OC]

Patient Protection and Affordable Care Act: establish a deficit-neutral reserve fund to repeal amendments which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, S1857 [25MR]

Pharmaceuticals: allow personal importation of safe and affordable drugs from approved pharmacies in Canada, S8351 [3DE]

——— condemn and call for investigation of pharmaceutical companies purchasing rights of existing drugs and drastically increasing the price of such drugs, S7118 [5OC]

——— ensure greater affordability of prescription drugs (S. 2023), S6997, S6998 [29SE]

Social Security: reform, S1482 [12MR], S4821 [8JY]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (S. 987), S2249 [16AP]

Trump, Donald: characterization of remarks relative to immigration, S5179 [21JY]

Urban areas: making emergency supplemental appropriations to address critical challenges and rebuild inner city neighborhoods (S. 1889), S6182 [30JY]

Reports filed

Commission on Native Children Act: Committee on Indian Affairs (Senate) (S. 246) (S. Rept. 114–39), S2759 [11MY]

Comprehensive Justice and Mental Health Act: Committee on the Judiciary (Senate) (S. 993), S2566 [30AP]

Consideration of H.R. 6, 21st Century Cures Act: Committee on Rules (House) (H. Res. 350) (H. Rept. 114–193), H4954 [8JY]

Dept. of HHS National All Schedules Prescription Electronic Reporting (NASPER) Grant Program Amendment and Reauthorization: Committee on Energy and Commerce (House) (H.R. 1725) (H. Rept. 114–245), H5846 [8SE]

Electronic Health Fairness Act: Committee on Finance (Senate) (S. 1347) (S. Rept. 114–106), S6186 [30JY]

——— Committee on Ways and Means (House) (H.R. 887) (H. Rept. 114–40), H1635 [13MR]

Ensuring Patient Access and Effective Drug Enforcement Act: Committee on Energy and Commerce (House) (H.R. 471) (H. Rept. 114–85), H2318 [20AP]

First Responder Anthrax Preparedness Act: Committee on Homeland Security (House) (H.R. 1300) (H. Rept. 114–222), H5401 [22JY]

Improving Regulatory Transparency for New Medical Therapies Act: Committee on Energy and Commerce (House) (H.R. 639) (H. Rept. 114–41), H1660 [16MR]

——— Committee on Health, Education, Labor, and Pensions (Senate) (S. 481), S7101 [1OC]

Mental Health Awareness and Improvement Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1893), S7101 [1OC]

Nomination of Michael P. Botticelli To Be Office of National Drug Control Policy Director: Committee on the Judiciary (Senate), S832 [5FE]

Northern Border Security Review Act: Committee on Homeland Security and Governmental Affairs (Senate) (S. 1808) (S. Rept. 114–155), S7304 [19OC]

——— Committee on Homeland Security (House) (H.R. 455) (H. Rept. 114–232), H5587 [28JY]

Preservation of Access for Seniors in Medicare Advantage Act: Committee on Ways and Means (House) (H.R. 2581) (H. Rept. 114–161), H4430 [16JN]

Protecting Our Infants Act: Committee on Energy and Commerce (House) (H.R. 1462) (H. Rept. 114–244), H5846 [8SE]

——— Committee on Health, Education, Labor, and Pensions (Senate) (S. 799), S7101 [1OC]

Protecting the Integrity of Medicare Act: Committee on Ways and Means (House) (H.R. 1021) (H. Rept. 114–46), H1767 [18MR]

Restoring Access to Medication Act: Committee on Ways and Means (House) (H.R. 1270) (H. Rept. 114–308), H7173 [23OC]

Sentencing Reform and Corrections Act: Committee on the Judiciary (Senate) (S. 2123), S7491 [26OC]

Transnational Drug Trafficking Act: Committee on the Judiciary (Senate) (S. 32), S6809 [17SE]

21st Century Cures Act: Committee on Energy and Commerce (House) (H.R. 6) (H. Rept. 114–190), H4860 [7JY]

Statements

Centers for Disease Control and Prevention Whistleblower Allegations Relative to Intentional Omission of Findings From Study Examining Possible Relationship Between Certain Vaccines and Autism: William Thompson, H5602 [29JY]

Continuing America’s Leadership in Medical Innovation for Patients: Senator Alexander, Committee on Health, Education, Labor, and Pensions (Senate), S1490 [12MR]

Reemergence of Vaccine-Preventable Diseases—Exploring the Public Health Successes and Challenges: Senator Alexander, Committee on Health, Education, Labor and Pensions (Senate), S979 [12FE]

Tables

Price comparison of prescription drugs offered in the U.S. and Canada, S6997 [29SE]

Texts of

H. Res. 350, consideration of H.R. 6, 21st Century Cures Act, H4976 [9JY]

H.R. 6, 21st Century Cures Act, H5035–H5069 [10JY]

H.R. 361, Medical Preparedness Allowable Use Act, H675 [2FE]

H.R. 455, Northern Border Security Review Act, H7316 [28OC]

H.R. 471, Ensuring Patient Access and Effective Drug Enforcement Act, H2329 [21AP]

H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act, H1638 [16MR], H8212 [16NO]

H.R. 1300, First Responder Anthrax Preparedness Act, H5504 [27JY]

H.R. 1462, Protecting Our Infants Act, H5798 [8SE]

H.R. 1725, Dept. of HHS National All Schedules Prescription Electronic Reporting (NASPER) Grant Program amendment and reauthorization, H5796 [8SE]

H.R. 2570, Strengthening Medicare Advantage Through Innovation and Transparency for Seniors Act, H4479 [17JN]

S. 32, Transnational Drug Trafficking Act, S7223 [7OC]

S. 134, Industrial Hemp Farming Act, S102 [8JA]

S. 246, Commission on Native Children Act, S3381–S3383 [1JN]

S. 799, Protecting Our Infants Act, S1662 [19MR], S7439 [22OC], H8180 [16NO]

S. 987, Small Business Tax Equity Act, S2249 [16AP]

S. 993, Comprehensive Justice and Mental Health Act, S8614–S8617 [10DE]

S. 1347, Electronic Health Fairness Act, S6425 [5AU]

S. 1884, Medicare Prescription Drug Savings and Choice Act, S6139 [29JY]

S. 1893, Mental Health Awareness and Improvement Act, S8908–S8910, S8911–S8913 [18DE]

S. 2002, Mental Health and Safe Communities Act, S6392–S6401 [5AU]

S. Res. 108, commemorate discovery of polio vaccine and support Federal and international efforts to eradicate disease, S1784 [24MR]

S. Res. 233, World Hepatitis Day, S6077 [28JY]

S. Res. 328, designate a national day of remembrance for victims of drunken and drugged driving and for victims of consequences of underage drinking, S8381 [3DE]